Skip to content

Collegium Pharmaceutical, Inc. COLL Other operating expenses

Other operating expenses at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$139M-10.9%
Avanos Medical logo
Avanos MedicalAVNS
-$2.4M-250%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$2.28M+137%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$27.18M-8.9%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$22.1M+244%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s other operating expenses?
Collegium Pharmaceutical, Inc. (COLL) reported other operating expenses of $86.35M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s other operating expenses changed year-over-year?
Collegium Pharmaceutical, Inc.'s other operating expenses increased by 14.2% year-over-year, from $75.64M to $86.35M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s other operating expenses?
Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s other operating expenses has grown at a 20.8% compound annual growth rate (CAGR), from $132.99M to $283.62M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.